Clinical Profile and Plasma Vitamin B6 Levels in Children with Tourette Syndrome: A Case-control Study
Authors:
Open Access
- 16 May 2026
- journal article
- Published by SAGE Publications in Indian Journal of Psychological Medicine
Abstract
Background: Tourette syndrome (TS) is a childhood-onset neuropsychiatric disorder characterized by recurrent motor and vocal tics. Histaminergic dysregulation in the brain has been proposed as a mechanism underlying TS. Vitamin B6, a key cofactor in histamine metabolism, may therefore play a contributory role in its pathophysiology. Methods: This was an observational, unmatched case–control study in which clinical features of 25 children diagnosed with TS were assessed using the Yale Global Tic Severity Scale. Plasma vitamin B6 levels were measured using enzyme-linked immunosorbent assay (ELISA) and compared with those of a control group. Results: Most participants were males, and 16% had comorbid attention deficit hyperactivity disorder (ADHD) or obsessive–compulsive disorder (OCD). The most common motor tics were eye blinking, shoulder shrugging, head jerking, and orofacial movements. Frequent vocal tics included throat clearing and sniffing. Coprolalia was observed in four children. The median plasma vitamin B6 level in the TS group was 25.01 ng/mL, which was significantly lower than the 36.33 ng/mL in the control group (Mann–Whitney U = 225, p = .03). The rank-biserial correlation indicated a moderate effect size ( r = 0.35). Conclusions: TS in children predominantly affects males and is commonly associated with ADHD and OCD. Coprolalia—a clinically distressing symptom—was present only in a small subgroup. The lower plasma vitamin B6 levels observed in children with TS suggest a possible role for vitamin B6 in disease pathogenesis, potentially through its involvement in histaminergic and GABAergic neurotransmission and in modulating neuroinflammatory processes.Keywords
This publication has 29 references indexed in Scilit:
- A preliminary study of finasteride in Tourette syndromeMovement Disorders, 2011
- Tourette Syndrome in Children: An Updated ReviewPediatrics & Neonatology, 2010
- L-Histidine Decarboxylase and Tourette's SyndromeNew England Journal of Medicine, 2010
- New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6Trials, 2009
- Neural correlates of tic severity and cognitive control in children with Tourette syndromeBrain, 2007
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationAnnals of Internal Medicine, 2007
- Tourette syndrome, associated conditions and the complexities of treatmentBrain, 2000
- A Double-Blind, Placebo-Controlled, Crossover Trial of an Antiandrogen in the Treatment of Tourette's SyndromeJournal of Clinical Psychopharmacology, 1998
- Coprolalia in younger patients with Gilles de la tourette syndromeMovement Disorders, 1994
- The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic SeverityJournal of the American Academy of Child & Adolescent Psychiatry, 1989